osaühing RÄPINA APTEEK
RegisteredKey figures
Ratios
2025Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.
Summary: osaühing RÄPINA APTEEK
What kind of company is it?
Osaühing RÄPINA APTEEK (registry code 10240716) is a private limited company (OÜ). The company was entered in the Commercial Register in 1997 and has been registered for 29 years. Registered location: Räpina linn, Räpina vald, Põlva maakond. According to the latest annual report, the main activity is retail sale of pharmaceutical products (EMTAK 47731). The company is registered for VAT (VAT number EE100640865).
How is the company doing financially?
Revenue in financial year 2025 was 961 654 €, up 2,3% on the previous year (940 221 €). From 2019 to 2025, revenue grew by an average of 5,1% per year. This is the company's highest revenue among the published years (2019–2025). Net profit for financial year 2025 was 4450 € (0,5% of revenue). The company was profitable in 6 of the 7 published financial years. In financial year 2025 the company had 5 employees. Revenue per employee was 192 331 €. At the end of financial year 2025, total assets were 262 768 € and equity 116 283 € (44,3% of assets).
What do the latest quarters show?
According to the Tax and Customs Board, turnover in Q3 2026 was 255 491 €, up 9,6% on the same quarter a year earlier. The company had 6 employees in that quarter. Labour taxes paid in the quarter: 14 358 €. Based on labour taxes, the estimated average gross salary in Q3 2026 was about 1570 € per month.
Who runs the company and who owns it?
The management board has 3 members. According to the register, the company has 5 owners. The largest stake (51%) is held by a private individual.
Where does the data come from and how fresh is it?
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 19.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 255 491 € | 6 | 14 358 € |
| Q2 2026 | 247 390 € | 7 | 14 049 € |
| Q1 2026 | 252 987 € | 7 | 16 445 € |
| Q4 2025 | 249 728 € | 7 | 15 936 € |
| Q3 2025 | 233 097 € | 7 | 18 146 € |
| Q2 2025 | 237 219 € | 7 | 15 049 € |
| Q1 2025 | 239 754 € | 7 | 16 570 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculatedNo dividends were distributed.
Summary of financial statements2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 844 679 | 840 980 | 885 405 | 940 221 | 961 654 |
| Net profit | 26 720 | 19 165 | 8107 | 15 145 | 4450 |
| Retained earnings | 34 078 | 60 798 | 79 673 | 87 780 | 102 925 |
| Total assets | 193 667 | 227 828 | 226 980 | 245 906 | 262 768 |
| Total liabilities | 123 961 | 138 957 | 130 292 | 134 073 | 146 485 |
| Total equity | 69 706 | 88 871 | 96 688 | 111 833 | 116 283 |
| Employees | 5 | 5 | 5 | 5 | 5 |
| Average gross salary (monthly) | 1367 | 1544 | 1788 | 1848 | 1940 |
| Calculated dividend | 15 000 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligationsAll clear1 for information
Data from public registers, not a credit rating.
Connections graph
Click a node to see its other connections.
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
- Selver AS622 m €
- ORLEN Eesti OÜ609 m €
- AS Alexela555 m €
- Coop Eesti Keskühistu549 m €
- aktsiaselts Olerex543 m €